| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |